GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus

Group A Streptococcus (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we explored the possibil...

Full description

Bibliographic Details
Main Authors: Aruta, M.G (Author), Carducci, M. (Author), Di Benedetto, R. (Author), Gasperini, G. (Author), Kis, Z. (Author), Kontoravdi, C. (Author), Massai, L. (Author), Mawas, F. (Author), Micoli, F. (Author), Oldrini, D. (Author), Ozanne, J. (Author), Palmieri, E. (Author), Ricchetti, B. (Author), Rossi, O. (Author), Shah, N. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
glycoconjugate
GMMA
Group A Carbohydrate
Group A Streptococcus
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items